TY - JOUR
T1 - Prehypertension
T2 - Progression to hypertension and management considerations
AU - Persell, Stephen D.
N1 - Funding Information:
Dr. Persell has no financial conflicts of interest. He is supported in part by the Mentored Clinical Scientist Development award 1 K08 HS015647-01 from the Agency for Healthcare Research and Quality. Dr. Persell would like to thank Dr. Heather L. Heiman for valuable editorial input.
PY - 2007
Y1 - 2007
N2 - Prehypertension is a designation used by the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure to describe untreated adults with blood pressure of 120 to 139 mm Hg systolic or 80 to 89 mm Hg diastolic. As the term implies, prehypertension frequently progresses to hypertension, though weight loss, exercise, and dietary changes can lower blood pressure and reduce the chance of progression to hypertension. Prehypertension often occurs along with other cardiovascular risk factors, such as dyslipidemia and impaired glucose metabolism. Prehypertension also carries independent cardiovascular risk. Recent clinical trials indicate that drug therapy should be considered for stable patients with prehypertension at high risk for cardiovascular disease or stroke. Whether using antihypertensive medication in lower risk persons with prehypertension is advantageous is not known.
AB - Prehypertension is a designation used by the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure to describe untreated adults with blood pressure of 120 to 139 mm Hg systolic or 80 to 89 mm Hg diastolic. As the term implies, prehypertension frequently progresses to hypertension, though weight loss, exercise, and dietary changes can lower blood pressure and reduce the chance of progression to hypertension. Prehypertension often occurs along with other cardiovascular risk factors, such as dyslipidemia and impaired glucose metabolism. Prehypertension also carries independent cardiovascular risk. Recent clinical trials indicate that drug therapy should be considered for stable patients with prehypertension at high risk for cardiovascular disease or stroke. Whether using antihypertensive medication in lower risk persons with prehypertension is advantageous is not known.
UR - http://www.scopus.com/inward/record.url?scp=84873512810&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873512810&partnerID=8YFLogxK
U2 - 10.1007/s12170-007-0031-7
DO - 10.1007/s12170-007-0031-7
M3 - Article
AN - SCOPUS:84873512810
SN - 1932-9520
VL - 1
SP - 188
EP - 197
JO - Current Cardiovascular Risk Reports
JF - Current Cardiovascular Risk Reports
IS - 3
ER -